Found: 6
Select item for more details and to access through your institution.
Variations in the α<sub>2A</sub>-adrenergic receptor gene and their functional effects<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 2006, v. 79, n. 3, p. 173, doi. 10.1016/j.clpt.2005.10.006
- By:
- Publication type:
- Article
α<sub>1A</sub>-adrenergic Receptor Polymorphism and Vascular Response<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 2004, v. 75, n. 6, p. 539, doi. 10.1016/j.clpt.2004.02.006
- By:
- Publication type:
- Article
The effect of sildenafil on nitric oxide-mediated vasodilation in healthy men<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 2001, v. 70, n. 3, p. 270, doi. 10.1067/mcp.2001.117995
- By:
- Publication type:
- Article
Human β<sub>2</sub>-adrenergic receptor polymorphisms: No association with essential hypertension in black or white Americans<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 2000, v. 67, n. 6, p. 670, doi. 10.1067/mcp.2000.106293
- By:
- Publication type:
- Article
CYP2A6 genetic variation and dexmedetomidine disposition.
- Published in:
- European Journal of Clinical Pharmacology, 2012, v. 68, n. 6, p. 937, doi. 10.1007/s00228-011-1208-z
- By:
- Publication type:
- Article
Sildenafil does not improve nitric oxide-mediated endothelium-dependent vascular responses in smokers.
- Published in:
- British Journal of Clinical Pharmacology, 2004, v. 57, n. 2, p. 209, doi. 10.1046/j.1365-2125.2003.01974.x
- By:
- Publication type:
- Article